Clinical issues of resistance: Problematic microbes: Enterobacteriaceae

David F. Briceño, Julian A. Torres Isasiga, José D. Tafur, John P. Quinn, María V. Villegas

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Enterobacteriaceae are usual inhabitants of the lower gastrointestinal tract in humans and other animals, hence the term enterics as they are usually named. However, these organisms have been found colonizing different environments, including hospital settings, water, soil, and vegetation. Their importance in clinical settings has grown during the last decades because of increasing number of multi-resistant clinical isolates in the community as well as in the hospital setting. Antibiotic management for these infections can be a challenge, as inappropriate treatment has been associated with unfavorable outcomes. In this chapter, we will discuss the critical aspects of the family including the clinical features of the most important genera, the implications of resistance, and the treatment options for these pathogens.

Original languageEnglish (US)
Title of host publicationAntibiotic Discovery and Development
PublisherSpringer US
Pages651-678
Number of pages28
Volume9781461414001
ISBN (Electronic)9781461414001
ISBN (Print)1461413990, 9781461413998
DOIs
StatePublished - Apr 1 2012
Externally publishedYes

Fingerprint

Enterobacteriaceae
Lower Gastrointestinal Tract
Soil
Anti-Bacterial Agents
Water
Infection

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Briceño, D. F., Torres Isasiga, J. A., Tafur, J. D., Quinn, J. P., & Villegas, M. V. (2012). Clinical issues of resistance: Problematic microbes: Enterobacteriaceae. In Antibiotic Discovery and Development (Vol. 9781461414001, pp. 651-678). Springer US. https://doi.org/10.1007/978-1-4614-1400-1_20

Clinical issues of resistance : Problematic microbes: Enterobacteriaceae. / Briceño, David F.; Torres Isasiga, Julian A.; Tafur, José D.; Quinn, John P.; Villegas, María V.

Antibiotic Discovery and Development. Vol. 9781461414001 Springer US, 2012. p. 651-678.

Research output: Chapter in Book/Report/Conference proceedingChapter

Briceño, DF, Torres Isasiga, JA, Tafur, JD, Quinn, JP & Villegas, MV 2012, Clinical issues of resistance: Problematic microbes: Enterobacteriaceae. in Antibiotic Discovery and Development. vol. 9781461414001, Springer US, pp. 651-678. https://doi.org/10.1007/978-1-4614-1400-1_20
Briceño DF, Torres Isasiga JA, Tafur JD, Quinn JP, Villegas MV. Clinical issues of resistance: Problematic microbes: Enterobacteriaceae. In Antibiotic Discovery and Development. Vol. 9781461414001. Springer US. 2012. p. 651-678 https://doi.org/10.1007/978-1-4614-1400-1_20
Briceño, David F. ; Torres Isasiga, Julian A. ; Tafur, José D. ; Quinn, John P. ; Villegas, María V. / Clinical issues of resistance : Problematic microbes: Enterobacteriaceae. Antibiotic Discovery and Development. Vol. 9781461414001 Springer US, 2012. pp. 651-678
@inbook{3cec7b5ddbac4818a4d870d341a49f87,
title = "Clinical issues of resistance: Problematic microbes: Enterobacteriaceae",
abstract = "Enterobacteriaceae are usual inhabitants of the lower gastrointestinal tract in humans and other animals, hence the term enterics as they are usually named. However, these organisms have been found colonizing different environments, including hospital settings, water, soil, and vegetation. Their importance in clinical settings has grown during the last decades because of increasing number of multi-resistant clinical isolates in the community as well as in the hospital setting. Antibiotic management for these infections can be a challenge, as inappropriate treatment has been associated with unfavorable outcomes. In this chapter, we will discuss the critical aspects of the family including the clinical features of the most important genera, the implications of resistance, and the treatment options for these pathogens.",
author = "Brice{\~n}o, {David F.} and {Torres Isasiga}, {Julian A.} and Tafur, {Jos{\'e} D.} and Quinn, {John P.} and Villegas, {Mar{\'i}a V.}",
year = "2012",
month = "4",
day = "1",
doi = "10.1007/978-1-4614-1400-1_20",
language = "English (US)",
isbn = "1461413990",
volume = "9781461414001",
pages = "651--678",
booktitle = "Antibiotic Discovery and Development",
publisher = "Springer US",

}

TY - CHAP

T1 - Clinical issues of resistance

T2 - Problematic microbes: Enterobacteriaceae

AU - Briceño, David F.

AU - Torres Isasiga, Julian A.

AU - Tafur, José D.

AU - Quinn, John P.

AU - Villegas, María V.

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Enterobacteriaceae are usual inhabitants of the lower gastrointestinal tract in humans and other animals, hence the term enterics as they are usually named. However, these organisms have been found colonizing different environments, including hospital settings, water, soil, and vegetation. Their importance in clinical settings has grown during the last decades because of increasing number of multi-resistant clinical isolates in the community as well as in the hospital setting. Antibiotic management for these infections can be a challenge, as inappropriate treatment has been associated with unfavorable outcomes. In this chapter, we will discuss the critical aspects of the family including the clinical features of the most important genera, the implications of resistance, and the treatment options for these pathogens.

AB - Enterobacteriaceae are usual inhabitants of the lower gastrointestinal tract in humans and other animals, hence the term enterics as they are usually named. However, these organisms have been found colonizing different environments, including hospital settings, water, soil, and vegetation. Their importance in clinical settings has grown during the last decades because of increasing number of multi-resistant clinical isolates in the community as well as in the hospital setting. Antibiotic management for these infections can be a challenge, as inappropriate treatment has been associated with unfavorable outcomes. In this chapter, we will discuss the critical aspects of the family including the clinical features of the most important genera, the implications of resistance, and the treatment options for these pathogens.

UR - http://www.scopus.com/inward/record.url?scp=84949175243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949175243&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-1400-1_20

DO - 10.1007/978-1-4614-1400-1_20

M3 - Chapter

AN - SCOPUS:84949175243

SN - 1461413990

SN - 9781461413998

VL - 9781461414001

SP - 651

EP - 678

BT - Antibiotic Discovery and Development

PB - Springer US

ER -